The Ministry of Finance will pour 35 billion yuan into China Life Insurance Group, the nation's biggest life insurer, to fortify its balance sheet and risk resilience.
China Life Group said the injection would strengthen its ability to operate steadily and withstand risk, allowing it to focus on its core business, improve governance and pursue differentiated growth, according to a statement carried by Xinhua News Agency on Sept. 6.
The capital injection is part of a broader state effort to reinforce major financial institutions. China Taiping Insurance Group, another state-controlled insurer, is also set to receive capital support, according to earlier reports. China Life Insurance Group is the parent of China Life Insurance Co., which lists shares on the Shanghai Stock Exchange and in Hong Kong.
The move reflects Beijing's commitment to keeping the financial system stable and supporting state-owned enterprises. For China Life, the injection strengthens a capital position that underpins its solvency as the group underwrites life, health and annuity policies nationwide. State backing for a flagship insurer also carries weight beyond the company itself, showing the government's willingness to stand behind the broader insurance and financial sector.
Insurers in China have faced pressure on investment income as interest rates have fallen, squeezing the returns they earn on the large bond portfolios that back their policy liabilities. Capital injections from the state give these groups more room to absorb market swings and meet regulatory solvency requirements without scaling back new business.
Investors will watch whether further injections follow for other state-controlled insurers and how the capital boost affects China Life's listed arm. The group's listed unit, China Life Insurance Co., ranks among the largest life insurers in Asia by market value, making any shift in its capital position a closely tracked metric for the sector.
This article is for informational purposes only and does not constitute investment advice.